157 related articles for article (PubMed ID: 12120626)
1. [Extra pounds despite sports and diets. Genetics can also be involved].
MMW Fortschr Med; 2002 May; 144(19):63. PubMed ID: 12120626
[No Abstract] [Full Text] [Related]
2. [Weight reduction. Doubly effective with drug support].
MMW Fortschr Med; 2001 Apr; 143(15):42-3. PubMed ID: 11349320
[No Abstract] [Full Text] [Related]
3. [Effect of weight loss on blood pressure].
Bönner G
MMW Fortschr Med; 2007 Nov; 149(48):44-7; quiz 48. PubMed ID: 18161437
[TBL] [Abstract][Full Text] [Related]
4. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
Wirth A
MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
[No Abstract] [Full Text] [Related]
5. [Struggle about the best reducing diet, Fat gone by means of more fat?].
Bischoff A
MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569
[No Abstract] [Full Text] [Related]
6. [What effect does losing weight have on hypertension?].
Engeli S
MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
[No Abstract] [Full Text] [Related]
7. [Drugs and obesity: current status, prospects for the future].
Apfelbaum M
Rev Prat; 1984 Dec; 34(55):3121-4. PubMed ID: 6505592
[No Abstract] [Full Text] [Related]
8. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
9. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
[TBL] [Abstract][Full Text] [Related]
10. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
Barratt R; Frost G; O'Boyle A; Millward J; Truby H
J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
[TBL] [Abstract][Full Text] [Related]
11. Does weight loss prognosis depend on genetic make-up?
Moreno-Aliaga MJ; Santos JL; Marti A; Martínez JA
Obes Rev; 2005 May; 6(2):155-68. PubMed ID: 15836466
[TBL] [Abstract][Full Text] [Related]
12. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
[TBL] [Abstract][Full Text] [Related]
13. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
14. Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women.
Peters WR; MacMurry JP; Walker J; Giese RJ; Comings DE
Obes Res; 2003 Mar; 11(3):415-9. PubMed ID: 12634439
[TBL] [Abstract][Full Text] [Related]
15. [New therapies in obesity].
Bellido Guerrero D; Carreira Arias J
Rev Clin Esp; 1994 Aug; 194(8):636-46. PubMed ID: 7938846
[No Abstract] [Full Text] [Related]
16. A 'natural' weight loss product containing sibutramine.
van Hunsel F; Venhuis BJ; Keizers PH; Kant A
Drug Test Anal; 2016; 8(3-4):311-4. PubMed ID: 27072843
[No Abstract] [Full Text] [Related]
17. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
Vazquez Roque MI; Camilleri M; Clark MM; Tepoel DA; Jensen MD; Graszer KM; Kalsy SA; Burton DD; Baxter KL; Zinsmeister AR
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):829-37. PubMed ID: 17544870
[TBL] [Abstract][Full Text] [Related]
18. Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene.
Hsiao DJ; Wu LS; Huang SY; Lin E
Pharmacogenet Genomics; 2009 Sep; 19(9):730-3. PubMed ID: 19687782
[TBL] [Abstract][Full Text] [Related]
19. The development of tolerance to drugs that suppress food intake.
Fernstrom JD; Choi S
Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
[TBL] [Abstract][Full Text] [Related]
20. Medical strategies for weight loss in the overweight and obese patient.
Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
